Abstract Each year, about 5–6 cases out of 100,000 people are diagnosed with primary
malignant brain tumors, of which about 80% are malignant gliomas (MGs). Glioblastoma …

Glioblastoma is the most aggressive and the most common primary malignant brain tumor in
adults. Risk factors for glioblastoma are widely elusive and the clinical course is generally …

Malignant gliomas, the most common type of primary brain tumor in adults, are associated
with disproportionate cancer-related morbidity and mortality. Recently, there have been …

Glioblastoma (GBM) is the most deadly form of human cancer. Most patients diagnosed with
this WHO grade IV malignant glioma survive about 12 months. Despite international efforts …

PURPOSE: To give an overview of current available clinical data on reirradiation of glioma
with respect to the tolerance dose of normal brain tissue. METHODS AND MATERIALS …

Prognosis for patients suffering from malignant glioma has not substantially improved.
Specific immunotherapy as a novel treatment concept critically depends on target antigens …

The vast majority of primary brain tumors derive from glial cells and are collectively called
gliomas. While, they share some genetic mutations with other cancers, they do present with …

Glioma accounts for the majority of human brain tumors. With prevailing treatment regimens,
the patients have poor survival rates. In spite of current development in mainstream glioma …

Malignant gliomas are the most frequently occurring, devastating primary brain tumors, and
are coupled with a poor survival rate. Despite the fact that complete neurosurgical resection …

The current method for assessing the response to therapy of glial tumors was described by
Macdonald et al. in 1990. Under this paradigm, response categorization is determined on …